Skip to main content

Table 1 Number (%) of dogs treated once on Day 0 with fluralaner chewables or fluralaner spot-on or on multiple occasions with topical imidacloprid-moxidectin that were negative for live mites on Days 28, 56 and 84

From: A European field assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosis

 

Fluralaner

Imidacloprid-moxidectin

Oral (n = 50)

Spot-on (n = 50)

Topical (n = 24)

Mite free at Day 28

46 (92.0)

46 (92.0)

19 (79.2)

Mite free at Day 56

49 (98.0)

49 (98.0)

21 (87.5)

Mite free at Day 84

50 (100)

49 (98.0)

22 (91.7)

Mite free at Days 56 and 84

49 (98.0a)

49 (98.0)

21 (87.5)

  1. aOne dog treated with fluralaner chewable had 500 mites on Day 0, 52 on Day 28, 1 mite on Day 56 and 0 on Day 84 and had improved condition. This dog was considered a treatment failure because it was not free of mites on both Day 56 and Day 84